HBV Clinical Trials

8 recruiting

HBV Trials at a Glance

25 actively recruiting trials for hbv are listed on ClinicalTrialsFinder across 6 cities in 19 countries. The largest study group is Phase 2 with 5 trials, with the heaviest enrollment activity in Guangzhou, Chengdu, and Jinan. Lead sponsors running hbv studies include MagIA Diagnostics, Nanfang Hospital, Southern Medical University, and Qilu Hospital of Shandong University.

Browse hbv trials by phase

Treatments under study

About HBV Clinical Trials

Looking for clinical trials for HBV? There are currently 8 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new HBV trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about HBV clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 120 of 25 trials

Recruiting

Single-cell Multiomics and Spatiotemporal Omics Analyze the Mechanism of Liver Degenerative Disease

Liver NeoplasmLiver FibrosisHBV Infection+1 more
Nanfang Hospital, Southern Medical University240 enrolled1 locationNCT07265544
Recruiting

HBV Reactivation in Immunocompromised Patients (REANT STUDY)

HBV
Yaşar Bayındır, MD490 enrolled1 locationNCT07529171
Recruiting
Phase 1

A Trial to Evaluate the Efficacy and Safety of WGc0201 in Patients With Chronic Hepatitis B Virus Infection

Chronic Hepatitis B Virus (Hbv)
Jiyan Liu9 enrolled1 locationNCT07051187
Recruiting

Changes in Bile Acids and Microbiota in Patients With Hepatitis D Treated With Bulvertide

Hepatocellular CarcinomaHIV InfectionsCirrhosis, Liver+6 more
Fondazione Policlinico Universitario Agostino Gemelli IRCCS20 enrolled1 locationNCT07429864
Recruiting
Not Applicable

Prospective Clinical Performance Evaluation of the In-Vitro Diagnostics Medical Device MaGIA IBC for the CombIned screENing of HIV, Hepatitis B and Hepatitis C

Combined Point of Care Diagnostic of HIV, HBV and HCV
MagIA Diagnostics252 enrolled2 locationsNCT06082336
Recruiting

Clinical Performance Evaluation of MagIA IVD-MD Multiplex Testing (HIV/HBV/HCV/Syphilis)

HIVHBVHCV+3 more
MagIA Diagnostics2,950 enrolled2 locationsNCT07170748
Recruiting

Rapid T-cell Analysis Test in Patients With Chronic HBV and HBV/HDV Disease

HBVHBV/HDV
Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico300 enrolled1 locationNCT06372990
Recruiting

Analysis of Methylomic Features and Prognostic Risk Prediction in Patients With Hepatitis B-related Acute-on-chronic Liver Failure

HBV-related Liver CirrhosisHBV Related Acute-on-chronic Liver FailureHBV (Hepatitis B Virus)
Qilu Hospital of Shandong University100 enrolled1 locationNCT07275554
Recruiting
Phase 4

Combined Light, ExVivo, and Antivirals for Recipients of Lungs From HBV Donors

Hepatitis B Virus (HBV)Lung Transplant Recipient
University Health Network, Toronto20 enrolled1 locationNCT07189377
Recruiting

Immune Dynamics in the Natural History of Chronic HBV Infection

HBV InfectionHBV (Hepatitis B Virus)Chronic Hep B
Nanfang Hospital, Southern Medical University5,000 enrolled1 locationNCT07137247
Recruiting
Phase 1Phase 2

Study of LW231 in Participants With Chronic Hepatitis B

Chronic HBV Infection
Shanghai Longwood Biopharmaceuticals Co., Ltd.270 enrolled2 locationsNCT07179575
Recruiting

Risk Assessment for HBV-Related Liver Cancer

HBV-related Liver Cirrhosis
Sun Yat-sen University6,000 enrolled1 locationNCT07160946
Recruiting
Phase 2

Methylene Blue Treatment of Chronic Hepatitis B Virus Infection

Chronic HBV Infection
Fondazione Epatocentro Ticino10 enrolled1 locationNCT06887036
Recruiting

Real-world Study Evaluating the Long-term Outcomes of Pegylated Interferon α-2b Treatment in the Families With Clusters of HBV Infection and Unfavorable Prognosis - A Prospective, Controlled, Multicenter, Cohort Study

Hepatitis B, Chronic (CHB)Hepatitis BHepatitis B Virus (HBV)
First Affiliated Hospital Xi'an Jiaotong University1,500 enrolled2 locationsNCT07079150
Recruiting
Phase 2

A Study to Evaluate the Efficacy and Safety of Combination Therapy of BRII-179, BRII-835 and PEG-IFNα in Participants With Chronic Hepatitis B Virus (HBV) Infection (ENHANCE)

Chronic Hepatitis B Virus (HBV) Infection
Brii Biosciences Limited250 enrolled14 locationsNCT06650852
Recruiting

New HBV Infection Biomarkers: Clinical Characterization and Impact on Management

Chronic Hepatitis B Virus (HBV) Infection
Assistance Publique - Hôpitaux de Paris900 enrolled1 locationNCT06906016
Recruiting

Non-Invasive Model for Fibrosis Regression in HBV Patients

Chronic Hepatitis B Virus (HBV) InfectionLiver Fibrosis
Beijing Friendship Hospital1,100 enrolled1 locationNCT06874127
Recruiting

Single Cell Landscape of HBV-related Acute-on-chronic Liver Failure Patients

HBV Related Acute-on-chronic Liver Failure
Qilu Hospital of Shandong University21 enrolled1 locationNCT06865859
Recruiting

Study on the Treatment of Hepatitis B Virus(HBV) Infected Individuals With Peginterferon α-2b Combined With NA.

HBV
Xiangya Hospital of Central South University400 enrolled4 locationsNCT06746701
Recruiting

Access HBV Assays - European Union (EU) Clinical Trial Protocol -

HBV
Beckman Coulter, Inc.21,210 enrolled5 locationsNCT04904835